Macrocyclic compounds having the structure of Formula (A), or pharmaceutically acceptable salts thereof, are provided,wherein R1, R2, R3, R4 and R5 are defined herein. Also provided are pharmaceutical compositions comprising the macrocyclic compound and methods for treating cancer in a patient comprising administering to the patient the macrocyclic compound.